Exane Derivatives Gsk PLC Call Options Transaction History

Exane Derivatives

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 Apr 24, 2019	SELL	$38.57 - $42.69 $25,533 - $28,260	-662 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$37.8 - $42.69 $36,099 - $40,768	-955 Reduced 59.06%	662 $25,000
Q3 2018 Oct 24, 2018	BUY	$39.75 - $42.69 $3,816 - $4,098	96 Added 6.31%	1,617 $0
Q2 2018 Jul 19, 2018	BUY	$39.61 - $42.76 $20,240 - $21,850	511 Added 50.59%	1,521 $0
Q1 2018 Apr 30, 2018	SELL	$36.18 - $40.15 $1,809 - $2,007	-50 Reduced 4.72%	1,010 $0
Q4 2017 Jan 29, 2018	BUY	$35.34 - $41.9 $37,460 - $44,414	1,060	1,060 $0

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.